A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia
Public ClinicalTrials.gov record NCT01968980. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 52 Week, Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study To Assess The Efficacy, Safety And Tolerability Of Pf-04950615 In Subjects With Heterozygous Familial Hypercholesterolemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, randomized study in subjects with heterozygous familial hypercholesterolemia receiving highly effective statins to assess the safety, efficacy and tolerability of Bococizumab (PF-04950615; RN316) to lower LDL-C.
Study identification
- NCT ID
- NCT01968980
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 370 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 23, 2013 (Actual)
- Primary completion
- Apr 15, 2016 (Actual)
- Completion
- Apr 15, 2016 (Actual)
- Last update posted
- Jun 26, 2017
2013 – 2016
United States locations
- U.S. sites
- 22
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| IMD Medical Group | Los Angeles | California | 90020 | — |
| Hartford Hospital, JB704 | Hartford | Connecticut | 06102 | — |
| Best Quality Research, Inc. | Hialeah | Florida | 33016 | — |
| Medical Research Center | Miami | Florida | 33144 | — |
| Premier Research Associate, Inc | Miami | Florida | 33165 | — |
| Columbus Clinical Services, LLC | Miami | Florida | 33174 | — |
| NewPhase Clinical Trials, Corp. | Miami Beach | Florida | 33140 | — |
| Om Medical | Las Vegas | Nevada | 89119 | — |
| The University of North Carolina at Chapel Hill Center for Heart & Vascular Care | Chapel Hill | North Carolina | 27599-7075 | — |
| The University of North Carolina Hospitals - Clinical and Translational Research Center Clinic | Chapel Hill | North Carolina | 27599-7600 | — |
| Metabolic and Atherosclerosis Research Center | Cincinnati | Ohio | 45227 | — |
| Oklahoma Heart Hospital Physicians | Oklahoma City | Oklahoma | 73120 | — |
| Oklahoma Heart Hospital Research Foundation | Oklahoma City | Oklahoma | 73120 | — |
| Oklahoma Heart Hospital | Oklahoma City | Oklahoma | 73120 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| OnSite Clinical Solutions, LLC | Gaffney | South Carolina | 29340 | — |
| Galenos Research | Dallas | Texas | 75251 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Pioneer Research Solutions, Inc. | Houston | Texas | 77099 | — |
| Pioneer Research Solutions, Inc. | Sugar Land | Texas | 77479 | — |
| Focus Clinical Research, LLC | Draper | Utah | 84020 | — |
| Burke Internal Medicine & Research | Burke | Virginia | 22015 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 66 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01968980, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 26, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01968980 live on ClinicalTrials.gov.